CONCLUSION
In conclusion, concomitant administration of evogliptin and pioglitazone
showed similar glucose lowering effets with those of evogliptin alone
and no clinically significant pharmacokinetic interactions. Safe and
tolerability of concomitant administration was comparable to
administration of each drug alone.